Thyrocare Technologies Schedules Board Meeting for Quarterly Financial Review
Thyrocare Technologies Limited has announced that its Board of Directors will meet on July 23, 2026. The primary objective of this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter concluded on June 30, 2026.The company confirmed that the trading window for equity shares was closed on July 1, 2026, for designated persons and their immediate relatives. This closure remains in effect while the financial results are being finalized. The trading window is scheduled to reopen 48 hours after the official declaration of the unaudited financial results for the period ending June 30, 2026.
| Category | Details |
|---|---|
| Board Meeting Date | July 23, 2026 |
| Reporting Period | Quarter ended June 30, 2026 |
| Financial Statements | Unaudited Standalone and Consolidated Results |
| Trading Window Closure | July 1, 2026 |
THYROCARE Stock Price Movement
As of 1:41 PM, shares of Thyrocare Technologies Limited are slipping by 0.12% in live trading, currently at ₹529.6. The stock is active with a total volume of 161,529 shares as it trades within its intraday range.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.